Factor | Lugsomya2018 (20009)

Therapeutic marbofloxacin use

Swine | Grower-finisher

Marbofloxacin use broken up by treatment group

Resistance

Microbe

Outcome

Marbofloxacin
/

Escherichia coli

See: Figure 2	AMR+ (%)	AMR- (%)	Total (n)
Therapeutic AMU	41.40		70
No AMU	35.80		67